Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Astrocytoma 8Glioblastoma 5Prostatic Neoplasms 4Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Recurrence 3Lung Neoplasms 3Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Pituitary Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

Mitotane 10Cisplatin 9pembrolizumab 7Doxorubicin 6Etoposide 5Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4relacorilant 3cabozantinib 3Cytoreduction Surgical Procedures 3sodium thiosulfate 2cixutumumab 2cemiplimab 2camrelizumab 2apatinib 2Trastuzumab 2Suramin 2Radiotherapy 2Ipilimumab 2Dichlorodiphenyldichloroethane 2Cyclophosphamide 2tipifarnib 1pegfilgrastim 1milademetan 1lenvatinib 1iodophenyl metomidate 1gossypol acetic acid 1fludarabine phosphate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adrenocortical Carcinoma × antineoplaston AS 2-1 × Clear all
NCT00003453 2018-05-09

Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

Burzynski Research Institute

Phase 2 Terminated
6 enrolled 6 charts
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡